The pelletizing process for the production of pharmaceutical pellets - including extrusion and spheronization, production of pellets by powder layering and liquid layering and pelletization via melt and wet granulation processes.
Pharmaceutical pellets offer a number of additional features compared with conventional tablets. GEA is a market-leading supplier of pelletization equipment and process solutions, and can help you to select the system that best suits your needs.
Specialising in the design, build and supply of equipment for the production and laboratory development of pharmaceutical pellets (spheroids) by extrusion and spheronization, powder and liquid layering, high shear pellet processing, and
Showing 4 of 10
Committed to providing flexible, modular equipment to support research and development in the pharmaceutical industry, the multipurpose AirConnect from GEA delivers a range of fluid bed processing solutions for small-scale applications.
FlexStream is a multi-purpose processor that addresses the shortfalls of traditional fluid bed processing, including linear scale-up, fully contained loading and unloading for Pharmaceutical applications.
A complete range of technologies for R&D designed for specific applications, our small-scale range covers every aspect of pharma oral solid dosage production, from high shear mixers, fluid bed dryers and single pot systems to extruders and spheronizers, blenders and containment solutions, right through to tablet compression.
Built-in versatility - For maximum process flexibility, GEA can supply a single Fluid Bed unit or FlexStream fluid bed processing – granulation, drying & pellet coating in one unit.
The impact of global warming is increasingly apparent all over the world. Towns and cities everywhere face the same challenge: providing their communities with reliable, affordable, sustainably sourced heat. GEA spoke with an expert in the field, Kenneth Hoffmann, Manager, Heat Pumps at GEA Heating & Refrigeration Technologies, about tackling global warming faster.
Something caught Farmer Tom's eye. Instead of another product demo, GEA showcased innovations via AR. That's only the start of GEA's interactive digital farm.
GEA scientists are working with researchers at the Graz University of Technology to configure a homogenization process and technology that turns eucalyptus pulp into 3D-printed, organic structures mimicking human veins, arteries and other tissues.